Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2

Summary: During early obesity, pancreatic β cells compensate for increased metabolic demand through a transient phase of insulin hypersecretion that stabilizes blood glucose and forestalls diabetic progression. We find evidence that β cell O-GlcNAcylation, a nutrient-responsive post-translational pr...

Full description

Bibliographic Details
Main Authors: Amber Lockridge, Seokwon Jo, Eric Gustafson, Niklas Damberg, Ramkumar Mohan, Miranda Olson, Juan E. Abrahante, Emilyn U. Alejandro
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124720305581
_version_ 1818283732238336000
author Amber Lockridge
Seokwon Jo
Eric Gustafson
Niklas Damberg
Ramkumar Mohan
Miranda Olson
Juan E. Abrahante
Emilyn U. Alejandro
author_facet Amber Lockridge
Seokwon Jo
Eric Gustafson
Niklas Damberg
Ramkumar Mohan
Miranda Olson
Juan E. Abrahante
Emilyn U. Alejandro
author_sort Amber Lockridge
collection DOAJ
description Summary: During early obesity, pancreatic β cells compensate for increased metabolic demand through a transient phase of insulin hypersecretion that stabilizes blood glucose and forestalls diabetic progression. We find evidence that β cell O-GlcNAcylation, a nutrient-responsive post-translational protein modification regulated by O-GlcNAc transferase (OGT), is critical for coupling hyperlipidemia to β cell functional adaptation during this compensatory prediabetic phase. In mice, islet O-GlcNAcylation rises and falls in tandem with the timeline of secretory potentiation during high-fat feeding while genetic models of β-cell-specific OGT loss abolish hyperinsulinemic responses to lipids, in vivo and in vitro. We identify the endoplasmic reticulum (ER) Ca2+ ATPase SERCA2 as a β cell O-GlcNAcylated protein in mice and humans that is able to rescue palmitate-stimulated insulin secretion through pharmacological activation. This study reveals an important physiological role for β cell O-GlcNAcylation in sensing and responding to obesity, with therapeutic implications for managing the relationship between type 2 diabetes and its most common risk factor.
first_indexed 2024-12-13T00:41:35Z
format Article
id doaj.art-c85a91f350514adc99fa3f058ddfc74f
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-13T00:41:35Z
publishDate 2020-05-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-c85a91f350514adc99fa3f058ddfc74f2022-12-22T00:05:07ZengElsevierCell Reports2211-12472020-05-01315Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2Amber Lockridge0Seokwon Jo1Eric Gustafson2Niklas Damberg3Ramkumar Mohan4Miranda Olson5Juan E. Abrahante6Emilyn U. Alejandro7Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USAIntegrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USAIntegrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USAIntegrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USAIntegrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USAIntegrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USASupercomputing Institute, University of Minnesota Medical School, Minneapolis, MN, USAIntegrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA; Corresponding authorSummary: During early obesity, pancreatic β cells compensate for increased metabolic demand through a transient phase of insulin hypersecretion that stabilizes blood glucose and forestalls diabetic progression. We find evidence that β cell O-GlcNAcylation, a nutrient-responsive post-translational protein modification regulated by O-GlcNAc transferase (OGT), is critical for coupling hyperlipidemia to β cell functional adaptation during this compensatory prediabetic phase. In mice, islet O-GlcNAcylation rises and falls in tandem with the timeline of secretory potentiation during high-fat feeding while genetic models of β-cell-specific OGT loss abolish hyperinsulinemic responses to lipids, in vivo and in vitro. We identify the endoplasmic reticulum (ER) Ca2+ ATPase SERCA2 as a β cell O-GlcNAcylated protein in mice and humans that is able to rescue palmitate-stimulated insulin secretion through pharmacological activation. This study reveals an important physiological role for β cell O-GlcNAcylation in sensing and responding to obesity, with therapeutic implications for managing the relationship between type 2 diabetes and its most common risk factor.http://www.sciencedirect.com/science/article/pii/S2211124720305581
spellingShingle Amber Lockridge
Seokwon Jo
Eric Gustafson
Niklas Damberg
Ramkumar Mohan
Miranda Olson
Juan E. Abrahante
Emilyn U. Alejandro
Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2
Cell Reports
title Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2
title_full Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2
title_fullStr Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2
title_full_unstemmed Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2
title_short Islet O-GlcNAcylation Is Required for Lipid Potentiation of Insulin Secretion through SERCA2
title_sort islet o glcnacylation is required for lipid potentiation of insulin secretion through serca2
url http://www.sciencedirect.com/science/article/pii/S2211124720305581
work_keys_str_mv AT amberlockridge isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2
AT seokwonjo isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2
AT ericgustafson isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2
AT niklasdamberg isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2
AT ramkumarmohan isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2
AT mirandaolson isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2
AT juaneabrahante isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2
AT emilynualejandro isletoglcnacylationisrequiredforlipidpotentiationofinsulinsecretionthroughserca2